131 related articles for article (PubMed ID: 10202609)
1. Tremorlytic activity of budipine in Parkinson's disease.
Spieker S; Eisebitt R; Breit S; Przuntek H; Müller D; Klockgether T; Dichgans J
Clin Neuropharmacol; 1999; 22(2):115-9. PubMed ID: 10202609
[TBL] [Abstract][Full Text] [Related]
2. Tremorlytic activity of budipine in Parkinson's disease.
Spieker S; Breit S; Klockgether T; Dichgans J
J Neural Transm Suppl; 1999; 56():165-72. PubMed ID: 10370910
[TBL] [Abstract][Full Text] [Related]
3. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J
Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185
[TBL] [Abstract][Full Text] [Related]
4. Budipine provides additional benefit in patients with Parkinson disease receiving a stable optimum dopaminergic drug regimen.
Przuntek H; Bittkau S; Bliesath H; Büttner U; Fuchs G; Glass J; Haller H; Klockgether T; Kraus P; Lachenmayer L; Müller D; Müller T; Rathay B; Sgonina J; Steinijans V; Teshmar E; Ulm G; Volc D
Arch Neurol; 2002 May; 59(5):803-6. PubMed ID: 12020263
[TBL] [Abstract][Full Text] [Related]
5. [Monotherapy of Parkinson's disease with budipine. A double blind comparison with amantadine].
Malsch U; Bliesath H; Böther K; Ramm H; Lühmann R
Fortschr Neurol Psychiatr; 2001 Feb; 69(2):86-9. PubMed ID: 11253562
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant treatment of Parksinson's disease with budipine: a double-blind trial versus placebo.
Jellinger K; Bliesath H
J Neurol; 1987 Jun; 234(5):280-2. PubMed ID: 3302121
[TBL] [Abstract][Full Text] [Related]
7. Budipine in Parkinson's tremor.
Reichmann H
J Neurol Sci; 2006 Oct; 248(1-2):53-5. PubMed ID: 16784759
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of budipine in Parkinson's disease.
Przuntek H; Müller T
J Neural Transm Suppl; 1999; 56():75-82. PubMed ID: 10370903
[TBL] [Abstract][Full Text] [Related]
9. [Modification of Parkinson tremor by budipine. A comparative study with amantadine].
Iizuka J; Fischer R
Nervenarzt; 1986 Mar; 57(3):184-6. PubMed ID: 3515215
[No Abstract] [Full Text] [Related]
10. Efficacy of budipine and placebo in untreated patients with Parkinson's disease.
Müller T; Kuhn W; Przuntek H
J Neural Transm (Vienna); 2005 Aug; 112(8):1015-23. PubMed ID: 15583956
[TBL] [Abstract][Full Text] [Related]
11. Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study.
Pogarell O; Gasser T; van Hilten JJ; Spieker S; Pollentier S; Meier D; Oertel WH
J Neurol Neurosurg Psychiatry; 2002 Jun; 72(6):713-20. PubMed ID: 12023411
[TBL] [Abstract][Full Text] [Related]
12. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial.
Möller JC; Oertel WH; Köster J; Pezzoli G; Provinciali L
Mov Disord; 2005 May; 20(5):602-10. PubMed ID: 15726540
[TBL] [Abstract][Full Text] [Related]
13. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
14. Double-blind comparison of pramipexole and bromocriptine treatment with placebo in advanced Parkinson's disease. International Pramipexole-Bromocriptine Study Group.
Guttman M
Neurology; 1997 Oct; 49(4):1060-5. PubMed ID: 9339690
[TBL] [Abstract][Full Text] [Related]
15. 'Atypical' tremor.
Henderson JM; Einstein R; Jackson DM; Byth K; Morris JG
Eur Neurol; 1995; 35(6):321-6. PubMed ID: 8591798
[TBL] [Abstract][Full Text] [Related]
16. Tremor and dopamine agonists.
Elble RJ
Neurology; 2002 Feb; 58(4 Suppl 1):S57-62. PubMed ID: 11909986
[TBL] [Abstract][Full Text] [Related]
17. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.
Parkinson Study Group
JAMA; 2000 Oct; 284(15):1931-8. PubMed ID: 11035889
[TBL] [Abstract][Full Text] [Related]
18. The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.
Castro-Caldas A; Delwaide P; Jost W; Merello M; Williams A; Lamberti P; Aguilar M; Del Signore S; Cesaro P;
Mov Disord; 2006 Apr; 21(4):500-9. PubMed ID: 16267842
[TBL] [Abstract][Full Text] [Related]
19. Postural tremor of Parkinson's disease.
Henderson JM; Yiannikas C; Morris JG; Einstein R; Jackson D; Byth K
Clin Neuropharmacol; 1994 Jun; 17(3):277-85. PubMed ID: 9316673
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine versus levodopa in early Parkinson's disease.
Ramaker C; van Hilten JJ
Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
